Matches in Nanopublications for { ?s ?p "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP663596.RAAxeCxvoRY9t_lcD6akKb-mnd7C31ZLRsrZdEAENaSoU130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663596.RAAxeCxvoRY9t_lcD6akKb-mnd7C31ZLRsrZdEAENaSoU130_provenance.
- NP794333.RAIL6_5i8GhOez7TsUIrYkMAIC2yGkjboWn8NDii6DWE0130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794333.RAIL6_5i8GhOez7TsUIrYkMAIC2yGkjboWn8NDii6DWE0130_provenance.
- NP343487.RAVCOylJMitZA3nNxAntg_y1GIkDcA4HH_VBHlA8dwc-4130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343487.RAVCOylJMitZA3nNxAntg_y1GIkDcA4HH_VBHlA8dwc-4130_provenance.
- assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP111236.RA3QYbO3GQ_rQuYEZ4od4u_ajncwfpMQ3RMhjreheLO8A130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111236.RA3QYbO3GQ_rQuYEZ4od4u_ajncwfpMQ3RMhjreheLO8A130_provenance.
- NP126278.RAudIIesZ3Gj2zS4GY15ZJqzJ1cTyiUDH26H57eRcDtTw130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126278.RAudIIesZ3Gj2zS4GY15ZJqzJ1cTyiUDH26H57eRcDtTw130_provenance.
- assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627554.RAGUGBKfN4IYmRwsUSKWfmQ5NtjDIJpDjXeC-C59HYMMU130_provenance.
- NP627553.RAm471m6Iad0TMyRzsnXRrsnzp6OJZeYRFgsvrq7J2_7I130_assertion description "[Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627553.RAm471m6Iad0TMyRzsnXRrsnzp6OJZeYRFgsvrq7J2_7I130_provenance.